Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer
Quantitative RT-PCR (qRT-PCR)
Total RNA was extracted from cells with the RNeasy mini kit (Qiagen).
Complementary DNA was synthesized from 0.5 μg of total RNA using the ImProm-II Reverse Transcription System (Promega). qPCR was performed using the 7500 StepOne Plus RealTime PCR System and the Taqman Gene Expression Master Mix (Applied Biosystems) and a C1000™-CFX384 Thermal Cycler Real-Time System apparatus (Bio-Rad). Thermal cycling was initiated with a denaturation step at 95ºC for 10 min and consisted of 40 cycles (denaturation at 95ºC for 10 s, annealing and elongation at 60ºC for 60 s). Taqman probes (Applied Biosystems) used: AKR1C3 (Hs00366267_m1), ALDH1A1 (Hs00946916_m1), TGFB2 (Hs00234244_m1), REPS2 (Hs00190932_m1), GSDMA (Hs00937853_m1), SAMD9 (Hs_00415836_m1), SLPI (Hs00268204_m1), and IQGAP2 (Hs00183606_m1). The expression levels were normalized to the levels of ribosomal protein control RPLPO (Taqman probe set 4310879E). All experiments were performed in triplicate. Human samples: RNAs were purified from formalin-fixed paraffin-embedded samples human non-pathological colon (n = 10), and from primary tumors (n = 12) and liver metastsis (n = 13) of mCRC patients.
Construction of the DKK-1 lentiviral vector and production of lentiviral particles
The Tet-On inducible lentiviral vector was based on the pRRL-cPPT-hPGK-mcs-WPRE with the reporter gene MuSEAP encoded under the control of the hPGK promoter (kindly provided by Dr. O. Danos, University College, London). To introduce the sequence of IRES-eGFP the MuSEAP was excised using MluI/EcoRV enzymes. The IRES-eGFP sequence was amplified from an intermediate vector, and restriction sites were introduced by PCR (forward 5' acgcacgcgtgcccctctccctccc 3'; reverse 5' acgcgatatctcgagtgcggccgcttta 3'), and then inserted into MluI/EcoRV sites. For the hDKK1-IRES-eGFP the cloning was done in two steps: first we introduced the hDKK1 sequence from the pCDNA3.1/V5HisA plasmid, into an intermediate vector pENTR1A-IRES-eGFP, and restriction sites SalI/BamHI as well as a stop codon after the V5 sequence, were introduced by PCR (forward 5´ acgcgtcgacatgatggctctgggcgcagc 3'; reverse 5´acgcggatccttacgtagaatcgagaccga 3'). Secondly, and using the same strategy used for IRES-eGFP, the full sequence of hDKK-1-V5-pIRESeGFP was amplified and restriction sites introduced by PCR (forward 5´acgcacgcgtatgatggctctgggcgc 3'; reverse 5´acgcgatatctcgagtgcggccgcttta 3'), and inserted into MluI/EcoRV sites. Lentiviruses were produced as previously described 
